PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-52.47%
Both yoy net incomes decline, with CRK at -50.62%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.52%
Both reduce yoy D&A, with CRK at -30.23%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-35.39%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
102.54%
Well above CRK's 200.85% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
102.54%
Growth of 102.54% while CRK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-104.47%
Both negative yoy, with CRK at -109.69%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
2.05%
Some CFO growth while CRK is negative at -50.45%. John Neff would note a short-term liquidity lead over the competitor.
16.35%
Lower CapEx growth vs. CRK's 59.81%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.21%
Growth of 152.21% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
50.84%
Investing outflow well above CRK's 59.87%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-62.65%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-0.41%
Negative yoy issuance while CRK is 101271.43%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-38.03%
We cut yoy buybacks while CRK is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.